Abstract:Abstract Background Keloids are an extreme form of abnormal scarring that result from a pathological fibroproliferative wound healing process. The molecular mechanisms driving keloid pathology remain incompletely understood, hindering development of targeted, effective therapies. Recent studies in our laboratory demonstrated that keloid keratinocytes exhibit adhesion abnormalities and display a transcriptional signature reminiscent of cells undergoing epithelial-mesenchymal transition (EMT), suggesting a role for EMT in keloid pathology. In the current study, we further define the EMT-like phenotype of keloid scars and investigate regulation of EMT-related genes in keloid. Methods Primary keratinocytes from keloid scar and normal skin were cultured in the presence or absence of transforming growth factor beta 1 (TGF-β1) +/− inhibitors of TGF-β1 and downstream signaling pathways. Gene expression was measured using quantitative polymerase chain reaction. Migration was analyzed using an in vitro wound healing assay. Proteins in keloid scar and normal skin sections were localized by immunohistochemistry. Statistical analyses utilized SigmaPlot (SyStat Software, San Jose, CA) or SAS® (SAS Institute, Cary, NC). Results In keloid and normal keratinocytes, TGF-β1 regulated expression of EMT-related genes, including hyaluronan synthase 2, vimentin, cadherin-11, wingless-type MMTV integration site family, member 5A, frizzled 7, ADAM metallopeptidase domain 19, and interleukin-6. Inhibition of canonical TGF-β1 signaling in keloid keratinocytes significantly inhibited expression of these genes, and TGF-β1 stimulation of normal keratinocytes increased their expression. The inhibition of the extracellular signal-regulated kinase 1/2 (ERK1/2) signaling pathway or the p38 mitogen-activated protein kinase pathway attenuated TGF-β1-induced expression of subsets of these genes. Migration of keloid keratinocytes, previously shown to be increased compared with normal keratinocytes, was significantly reduced by inhibition of TGF-β1 or ERK1/2 signaling. Biomarkers of EMT, including reduced E-cadherin and increased active β-catenin, were observed in keloid epidermis in vivo. However, evidence of basement membrane breakdown in keloid scar was not observed. Conclusions The results suggest that keloid keratinocytes exist in an EMT-like metastable state, similar to activated keratinocytes in healing wounds. The EMT-like gene expression pattern of keloid keratinocytes is regulated by canonical and non-canonical TGF-β1 signaling pathways. Therefore, interventions targeting TGF-β1-regulated EMT-like gene expression in keloid keratinocytes may serve to suppress keloid scarring.

TLR3 activation mediates partial epithelial-to-mesenchymal transition in human keratinocytes

Toll-Like Receptor 3 Activation Is Required for Normal Skin Barrier Repair Following UV Damage

Activation of VEGFR-2 Signaling in Response to Moderate Dose of Ultraviolet B Promotes Survival of Normal Human Keratinocytes

Increased MAPK and NF-κB Expression of Langerhans Cells is Dependent on TLR2 and TLR4, and Increased IRF-3 Expression is Partially Dependent on TLR4 Following UV Exposure

Characterization of a non‐canonical role for Tcf3 in skin tumorigenesis

Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes

Chemokine expression by human keratinocyte cell lines after activation of Toll-like receptors

The chemokine receptor CCR3 participates in tissue remodeling during atopic skin inflammation

Regulatory T cells promote innate inflammation after skin barrier breach via TGF-β activation

Partial epithelial-mesenchymal transition in keloid scars: regulation of keloid keratinocyte gene expression by transforming growth factor-β1

PRSS3/mesotrypsin as a putative regulator of the biophysical characteristics of epidermal keratinocytes in superficial layers

TLR2 and TLR4 expression of keratinocytes in atopic dermatitis lesion

Roles of TLR3 in poly(I:C)- and UV- induced gene expressions in human dermal fibroblasts and mouse skin

Normality sensing licenses local T cells for innate-like tissue surveillance

New Mechanisms of Skin Innate Immunity: ASK1-mediated Keratinocyte Differentiation Regulates the Expression of Beta-Defensins, LL37, and TLR2.

Activation of Toll-like receptor 2 promotes mesenchymal stem/stromal cell-mediated immunoregulation and angiostasis through AKR1C1

T cells promote distinct transcriptional programs of cutaneous inflammatory disease in human skin structural cells

Dynamic Regulation of the Molecular Mechanisms of Regulatory T Cell Migration in Inflamed Skin

Human antimicrobial peptide LL-37 modulates proinflammatory responses induced by cytokine milieus and double-stranded RNA in human keratinocytes

Midkine Induces Epithelial-Mesenchymal Transition Through Notch2/Jak2-Stat3 Signaling in Human Keratinocytes

Characterization of TGF-β signaling in a human organotypic skin model reveals that loss of TGF-βRII induces invasive tissue growth